UC-MSCs release tiny packets of cellular proteins and nucleic acid materials called extracellular vesicles, which have powerful regenerative potential. They range from immune-modulatory properties to anti-inflammatory properties. Cytokine storm and increased pro-inflammatory signaling biomolecules are primarily responsible for COVID-19 pathogenesis, and the use of extracellular vesicles helps to reduce this pathogenesis. At the same time, it increases the level of anti-inflammatory signaling mediators that can reduce the severity of lung injury through increased permeability and functional aspects of the alveolar epithelium.

As a result, exchanging oxygen-rich air is easily facilitated and helps in the recovery of COVID-19 patients. The ability of this product to transfer mitochondria to alveolar cells further increases their survival rate and facilitates cellular regeneration by directly inhibiting viral multiplication.